Free Trial

4D Molecular Therapeutics (FDMT) Short Interest Ratio & Short Volume

$25.15
0.00 (0.00%)
(As of 05/24/2024 08:49 PM ET)

4D Molecular Therapeutics Short Interest Data

Current Short Interest
9,620,000 shares
Previous Short Interest
9,830,000 shares
Change Vs. Previous Month
-2.14%
Dollar Volume Sold Short
$230.21 million
Short Interest Ratio
11.1 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
51,700,000 shares
Percentage of Shares Shorted
18.61%
Today's Trading Volume
414,300 shares
Average Trading Volume
913,499 shares
Today's Volume Vs. Average
45%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling 4D Molecular Therapeutics ?

Sign up to receive the latest short interest report for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FDMT Short Interest Over Time

FDMT Days to Cover Over Time

FDMT Percentage of Float Shorted Over Time

4D Molecular Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20249,620,000 shares $230.21 million -2.1%N/A11.1 $23.93
4/15/20249,830,000 shares $258.04 million +5.5%N/A8.3 $26.25
3/31/20249,320,000 shares $296.94 million +9.7%N/A8 $31.86
3/15/20248,500,000 shares $267.84 million +1.9%N/A7.7 $31.51
2/29/20248,340,000 shares $233.69 million +18.1%N/A7.8 $28.02
2/15/20247,060,000 shares $195.49 million +83.9%N/A7.1 $27.69
1/31/20243,840,000 shares $66.24 million +33.3%N/A4.3 $17.25
1/15/20242,880,000 shares $54.14 million -10.6%N/A7.7 $18.80
12/31/20233,220,000 shares $65.24 million -18.1%N/A8.8 $20.26
12/15/20233,930,000 shares $69.80 million +9.2%N/A10.8 $17.76
11/30/20233,600,000 shares $45.79 million -4.5%N/A10.6 $12.72
11/15/20233,770,000 shares $41.70 million +7.4%N/A11.2 $11.06
10/31/20233,510,000 shares $37.70 million -14.4%N/A10.6 $10.74
10/15/20234,100,000 shares $42.89 million +4.3%N/A13 $10.46
9/30/20233,930,000 shares $50.03 million +6.5%N/A13.6 $12.73
9/15/20233,690,000 shares $57.42 million +3.4%N/A12.3 $15.56
8/31/20233,570,000 shares $58.12 million No ChangeN/A9.4 $16.28
8/15/20233,570,000 shares $59.48 million +15.5%N/A8.6 $16.66
7/31/20233,090,000 shares $56.55 million -0.6%N/A6.5 $18.30
7/15/20233,110,000 shares $58.84 million -11.4%N/A5.3 $18.92
6/30/20233,510,000 shares $63.43 million +2.6%N/A5.5 $18.07
6/15/20233,420,000 shares $71.82 million +10.0%N/A5.4 $21.00
5/31/20233,110,000 shares $57.10 million +4.7%N/A5.2 $18.36
5/15/20232,970,000 shares $52.93 million +4.6%N/A5.4 $17.82
4/30/20232,840,000 shares $51.15 million -10.1%N/A5.6 $18.01
4/15/20233,160,000 shares $51.10 million +1.3%N/A8 $16.17
3/31/20233,120,000 shares $53.63 million +19.5%N/A8.8 $17.19
3/15/20232,610,000 shares $45.34 million +23.7%N/A7.6 $17.37
2/28/20232,110,000 shares $40.60 million -5.4%N/A6.3 $19.24
2/15/20232,230,000 shares $41.19 million +2.8%N/A6.1 $18.47
1/31/20232,170,000 shares $45.68 million -3.6%N/A4.5 $21.05
1/15/20232,250,000 shares $49.57 million +8.7%N/A4.4 $22.03
12/30/20222,070,000 shares $45.97 million +11.9%N/A3.9 $22.21
12/15/20221,850,000 shares $42.72 million -19.2%N/A3.2 $23.09
11/30/20222,290,000 shares $55.35 million -15.2%N/A4.2 $24.17
11/15/20222,700,000 shares $50.46 million -6.9%N/A5.5 $18.69
10/31/20222,900,000 shares $25.11 million -1.7%N/A9.1 $8.66
10/15/20222,950,000 shares $20.74 million +87.9%N/A10.6 $7.03
9/30/20221,570,000 shares $12.62 million +7.5%N/A6.3 $8.04
9/15/20221,460,000 shares $13.49 million -2.7%N/A7.6 $9.24
Discover AI Giants? (Ad)

Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Download Your Free Report Now]
8/31/20221,500,000 shares $11.79 million -3.9%N/A6.5 $7.86
8/15/20221,560,000 shares $14.90 million -3.7%N/A6.5 $9.55
7/31/20221,620,000 shares $15.23 million -5.3%N/A6.1 $9.40
7/15/20221,710,000 shares $17.24 million -2.8%N/A6.3 $10.08
6/30/20221,760,000 shares $12.28 million -17.4%N/A6.4 $6.98
6/15/20222,130,000 shares $12.57 million +7.6%N/A8 $5.90
5/31/20221,980,000 shares $15.03 million +4.8%N/A9.7 $7.59
5/15/20221,890,000 shares $17.03 million -3.6%N/A9.1 $9.01
4/30/20221,960,000 shares $23.34 million +3.2%N/A9.7 $11.91
4/15/20221,900,000 shares $25.12 million +5.6%N/A9 $13.22
3/31/20221,800,000 shares $27.22 million +1.1%N/A8.4 $15.12
3/15/20221,780,000 shares $25.04 million -0.6%N/A8 $14.07
2/28/20221,790,000 shares $24.52 million +7.8%N/A6.2 $13.70
2/15/20221,660,000 shares $25.78 million +6.4%N/A5.8 $15.53
1/31/20221,560,000 shares $24.65 million +10.6%5.9%5.5 $15.80
1/15/20221,410,000 shares $23.96 million +0.7%5.3%4.4 $16.99
12/31/20211,400,000 shares $30.72 million +64.1%5.3%4.5 $21.94
12/15/2021853,100 shares $17.71 million -3.1%3.2%2.7 $20.76
11/30/2021880,000 shares $20.24 million -25.4%3.5%3.4 $23.00
11/15/20211,180,000 shares $28.31 million -26.3%4.6%4.6 $23.99
10/29/20211,600,000 shares $38.45 million -1.2%6.3%6.8 $24.03
10/15/20211,620,000 shares $44.26 million +1.3%7.6%9.7 $27.32
9/30/20211,600,000 shares $43.15 million +30.1%7.5%10.9 $26.97
9/15/20211,230,000 shares $41.96 million +18.3%5.8%7.6 $34.11
8/31/20211,040,000 shares $31.77 million +2.0%4.9%7.8 $30.55
8/13/20211,020,000 shares $27.55 million +2.1%4.8%8.2 $27.01
7/30/2021999,400 shares $24.86 million +0.4%4.8%7.9 $24.87
7/15/2021995,000 shares $23.19 million +5.1%4.8%7.4 $23.31
6/30/2021947,200 shares $22.81 million -6.2%4.6%6.8 $24.08
6/15/20211,010,000 shares $27.47 million +14.3%4.9%7.6 $27.20
5/28/2021883,800 shares $23.47 million +8.1%4.3%6.2 $26.56
5/14/2021817,500 shares $21.60 million -1.2%3.9%5.2 $26.42
4/30/2021827,700 shares $31.75 million +21.5%4.0%5.3 $38.36
4/15/2021681,000 shares $25.66 million -9.4%3.3%4.3 $37.68
3/31/2021751,200 shares $28.96 million +63.1%3.6%4.6 $38.55
3/15/2021460,500 shares $23.20 million +1.3%2.2%2.7 $50.38
2/26/2021454,500 shares $19.68 million +72.0%2.2%2.1 $43.29
2/12/2021264,300 shares $13.92 million +67.9%1.4%1.2 $52.67
1/29/2021157,400 shares $6.61 million +55.1%0.8%0.6 $42.00
1/15/2021101,500 shares $4.67 million No Change0.5%0.4 $46.00

FDMT Short Interest - Frequently Asked Questions

What is 4D Molecular Therapeutics' current short interest?

Short interest is the volume of 4D Molecular Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 9,620,000 shares of FDMT short. Learn More on 4D Molecular Therapeutics' current short interest.

What is a good short interest ratio for 4D Molecular Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FDMT shares currently have a short interest ratio of 11.0. Learn More on 4D Molecular Therapeutics's short interest ratio.

Which institutional investors are shorting 4D Molecular Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 4D Molecular Therapeutics: Ikarian Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is 4D Molecular Therapeutics' short interest increasing or decreasing?

4D Molecular Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 9,620,000 shares, a decrease of 2.1% from the previous total of 9,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does 4D Molecular Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to 4D Molecular Therapeutics: BioCryst Pharmaceuticals, Inc. (16.30%), Vir Biotechnology, Inc. (6.63%), Tarsus Pharmaceuticals, Inc. (20.28%), Neumora Therapeutics, Inc. (12.27%), Ginkgo Bioworks Holdings, Inc. (20.84%), Autolus Therapeutics plc (1.32%), Relay Therapeutics, Inc. (8.69%), Cullinan Therapeutics, Inc. (10.23%), Scholar Rock Holding Co. (16.78%), Mesoblast Limited (0.79%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short 4D Molecular Therapeutics stock?

Short selling FDMT is an investing strategy that aims to generate trading profit from 4D Molecular Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 4D Molecular Therapeutics?

A short squeeze for 4D Molecular Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FDMT, which in turn drives the price of the stock up even further.

How often is 4D Molecular Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FDMT, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:FDMT) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners